Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 68622P109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • The Column Group II, LP

    Shares: 3,540,777 · Class: 3.6%

  • The Column Group II GP, LP

    Shares: 3,540,777 · Class: 3.6%

  • David V Goeddel

    Shares: 3,627,493 · Class: 3.7%

  • Peter Svennilson

    Shares: 3,644,118 · Class: 3.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-284976
Form type
SCHEDULE 13G/A
Filer
COLUMN GROUP II, LP
CIK
CIK 1600420
Filed
Nov 17, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub